Variant report

Variant	nsv997927
Chromosome Location	chr1:161612234-161668434
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:543)
CpG islands
(count:430)
Chromatin interactive
region (count:32)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:543 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr1:161617405-161617638	K562	blood:	n/a	n/a
2	ARID3A	chr1:161612578-161612808	K562	blood:	n/a	n/a
3	ATF1	chr1:161617495-161617716	K562	blood:	n/a	n/a
4	ATF1	chr1:161612496-161612813	K562	blood:	n/a	n/a
5	BATF	chr1:161617320-161617519	GM12878	blood:	n/a	n/a
6	BATF	chr1:161628390-161628591	GM12878	blood:	n/a	n/a
7	BATF	chr1:161613710-161613967	GM12878	blood:	n/a	n/a
8	BATF	chr1:161631862-161632140	GM12878	blood:	n/a	n/a
9	BATF	chr1:161629972-161630312	GM12878	blood:	n/a	chr1:161630148-161630159
10	BATF	chr1:161632780-161633280	GM12878	blood:	n/a	n/a
11	BATF	chr1:161623225-161623407	GM12878	blood:	n/a	chr1:161623329-161623340
12	BATF	chr1:161641596-161641847	GM12878	blood:	n/a	chr1:161641739-161641750
13	BATF	chr1:161623197-161623490	GM12878	blood:	n/a	chr1:161623329-161623340
14	BATF	chr1:161632500-161632938	GM12878	blood:	n/a	n/a
15	BCL11A	chr1:161632778-161633189	GM12878	blood:	n/a	chr1:161632917-161632926
16	BCL11A	chr1:161628378-161628677	GM12878	blood:	n/a	chr1:161628596-161628605
17	BCL11A	chr1:161629970-161630202	GM12878	blood:	n/a	n/a
18	BCL11A	chr1:161631882-161632048	GM12878	blood:	n/a	n/a
19	BCL11A	chr1:161630062-161630293	GM12878	blood:	n/a	n/a
20	BCL11A	chr1:161632564-161633286	GM12878	blood:	n/a	chr1:161632917-161632926
21	BCL11A	chr1:161628361-161628646	GM12878	blood:	n/a	chr1:161628596-161628605
22	BHLHE40	chr1:161617509-161617683	K562	blood:	n/a	n/a
23	BHLHE40	chr1:161617481-161617615	GM12878	blood:	n/a	n/a
24	BHLHE40	chr1:161652285-161652468	K562	blood:	n/a	n/a
25	CBX3	chr1:161641185-161641529	K562	blood:	n/a	n/a
26	CBX3	chr1:161617335-161617953	K562	blood:	n/a	n/a
27	CEBPB	chr1:161655349-161655505	K562	blood:	n/a	n/a
28	CEBPB	chr1:161612472-161612835	K562	blood:	n/a	n/a
29	CEBPB	chr1:161612472-161612831	K562	blood:	n/a	n/a
30	CEBPB	chr1:161612573-161612826	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr1:161623338-161623646	K562	blood:	n/a	n/a
32	CEBPB	chr1:161623376-161623760	K562	blood:	n/a	n/a
33	CEBPB	chr1:161631694-161632563	GM12878	blood:	n/a	n/a
34	CEBPB	chr1:161612565-161612831	K562	blood:	n/a	n/a
35	CEBPB	chr1:161634609-161634889	K562	blood:	n/a	n/a
36	CEBPB	chr1:161656087-161656256	K562	blood:	n/a	n/a
37	CEBPB	chr1:161634589-161634935	K562	blood:	n/a	n/a
38	CEBPD	chr1:161638270-161638551	K562	blood:	n/a	n/a
39	CTCF	chr1:161617340-161617490	HFF	foreskin:	n/a	n/a
40	CTCF	chr1:161617460-161617610	GM12864	blood:	n/a	chr1:161617533-161617554
41	CTCF	chr1:161612700-161612850	AoAF	blood vessel:	n/a	n/a
42	CTCF	chr1:161617400-161617550	GM12870	blood:	n/a	n/a
43	CTCF	chr1:161612620-161612770	AG04450	lung:	n/a	n/a
44	CTCF	chr1:161612686-161612817	LNCaP	prostate:	n/a	n/a
45	CTCF	chr1:161631740-161631890	GM12865	blood:	n/a	n/a
46	CTCF	chr1:161612708-161612807	Kidney_OC	kidney:	n/a	n/a
47	CTCF	chr1:161612720-161612870	HAc	cerebellar:	n/a	n/a
48	CTCF	chr1:161612677-161612809	Pancreas_OC	pancreas:	n/a	n/a
49	CTCF	chr1:161612600-161612750	HBMEC	blood vessel:	n/a	n/a
50	CTCF	chr1:161617382-161617745	K562	blood:	n/a	chr1:161617533-161617554

(count:430 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:161655056-161655106	Hepatocyte	liver:	n/a
2	chr1:161646918-161646968	NB4	blood:	n/a
3	chr1:161655029-161655079	HCM	heart:	n/a
4	chr1:161655056-161655106	Hepatocyte	liver:	n/a
5	chr1:161646918-161646968	NB4	blood:	n/a
6	chr1:161655029-161655079	HCM	heart:	n/a
7	chr1:161647536-161647586	HRPEpiC	eye:	n/a
8	chr1:161646918-161646968	AG09319	gingival:	n/a
9	chr1:161655895-161655945	SK-N-SH	brain:	n/a
10	chr1:161646918-161646968	GM19239	blood:	n/a
11	chr1:161646918-161646968	IMR90	lung:	fetal
12	chr1:161655029-161655079	HEK293	kidney:	embryo
13	chr1:161655029-161655079	Caco-2	colon:	n/a
14	chr1:161646918-161646968	HIPEpiC	eye:	n/a
15	chr1:161655056-161655106	GM12891	blood:	n/a
16	chr1:161647536-161647586	Hepatocyte	liver:	n/a
17	chr1:161655124-161655174	BJ	skin:	n/a
18	chr1:161646918-161646968	NHBE	bronchial:	n/a
19	chr1:161647536-161647586	Jurkat	blood:	n/a
20	chr1:161655056-161655106	ECC-1	luminal epithelium:	n/a
21	chr1:161646918-161646968	GM06990	blood:	n/a
22	chr1:161646918-161646968	GM12878	blood:	n/a
23	chr1:161655029-161655079	HUVEC	blood vessel:	n/a
24	chr1:161655895-161655945	HPAEpiC	pulmonary alveolar:	n/a
25	chr1:161655056-161655106	HCF	heart:	n/a
26	chr1:161647536-161647586	HepG2	liver:	n/a
27	chr1:161647536-161647586	T-47D	breast:	n/a
28	chr1:161655029-161655079	H1-hESC	embryonic stem cell:	embryo
29	chr1:161646918-161646968	HPAEpiC	pulmonary alveolar:	n/a
30	chr1:161655124-161655174	NHDF-neo	bronchial:	n/a
31	chr1:161646918-161646968	BJ	skin:	n/a
32	chr1:161647536-161647586	MCF-7	breast:	n/a
33	chr1:161647536-161647586	MCF10A-Er-Src	breast:	n/a
34	chr1:161655895-161655945	SK-N-MC	brain:	n/a
35	chr1:161654727-161654777	HMEC	breast:	n/a
36	chr1:161655124-161655174	ovcar-3	ovarian:	n/a
37	chr1:161655029-161655079	HEEpiC	esophagus:	n/a
38	chr1:161654727-161654777	GM06990	blood:	n/a
39	chr1:161655056-161655106	ProgFib	skin:	n/a
40	chr1:161654727-161654777	HCM	heart:	n/a
41	chr1:161655029-161655079	PrEC	prostate:	n/a
42	chr1:161654727-161654777	HPAEpiC	pulmonary alveolar:	n/a
43	chr1:161647536-161647586	NH-A	brain:	n/a
44	chr1:161655029-161655079	ovcar-3	ovarian:	n/a
45	chr1:161647536-161647586	GM12892	blood:	n/a
46	chr1:161654727-161654777	AoSMC	blood vessel:	n/a
47	chr1:161655124-161655174	GM19239	blood:	n/a
48	chr1:161655124-161655174	PrEC	prostate:	n/a
49	chr1:161646918-161646968	HMEC	breast:	n/a
50	chr1:161647536-161647586	U87	brain:	n/a

(count:32 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:161651228..161654448-chr1:161657471..161660197,3	K562	blood:
2	chr1:161646369..161648546-chr1:161652642..161654817,3	MCF-7	breast:
3	chr1:161645664..161648632-chr1:161696817..161700044,3	K562	blood:
4	chr1:161616209..161618831-chr1:161708579..161712751,3	MCF-7	breast:
5	chr1:161559849..161561935-chr1:161640702..161643134,2	K562	blood:
6	chr1:161651228..161654448-chr1:161657471..161660197,3	K562	blood:
7	chr1:161648385..161650314-chr1:161696093..161698220,2	K562	blood:
8	chr1:161640986..161643411-chr1:161696404..161699095,2	MCF-7	breast:
9	chr1:161617196..161618017-chr1:161708253..161708755,2	MCF-7	breast:
10	chr1:161650813..161652496-chr1:161694475..161697078,2	MCF-7	breast:
11	chr1:161657417..161659539-chr1:161696325..161698709,3	K562	blood:
12	chr1:161652989..161655600-chr1:161660399..161662387,2	K562	blood:
13	chr1:161616464..161620281-chr1:161694638..161697565,4	MCF-7	breast:
14	chr1:161624063..161625619-chr1:161692402..161694799,2	MCF-7	breast:
15	chr1:161667456..161669424-chr1:161676316..161679255,2	MCF-7	breast:
16	chr1:161667779..161671071-chr1:161673847..161676940,3	K562	blood:
17	chr1:161615855..161618942-chr1:161693041..161695916,3	K562	blood:
18	chr1:161622695..161624632-chr1:161694566..161696294,2	MCF-7	breast:
19	chr1:161616816..161618830-chr1:161691616..161693924,2	MCF-7	breast:
20	chr1:161660940..161664279-chr1:161695176..161698462,3	K562	blood:
21	chr1:161645398..161648311-chr1:161695127..161698658,3	MCF-7	breast:
22	chr1:161646892..161649318-chr1:161652568..161655060,2	K562	blood:
23	chr1:161615132..161619077-chr1:161695627..161698654,3	MCF-7	breast:
24	chr1:161536027..161536622-chr1:161617103..161617839,3	MCF-7	breast:
25	chr1:161651291..161653505-chr1:161696476..161699114,3	K562	blood:
26	chr1:161617105..161617670-chr1:161711057..161711617,2	MCF-7	breast:
27	chr1:161645887..161649540-chr1:161691296..161697386,6	MCF-7	breast:
28	chr1:161617120..161618031-chr1:161708194..161708800,2	K562	blood:
29	chr1:161528077..161530889-chr1:161610740..161612765,2	K562	blood:
30	chr1:161646369..161648546-chr1:161652642..161654817,3	MCF-7	breast:
31	chr1:161646936..161648819-chr1:161691795..161694064,2	K562	blood:
32	chr1:161652344..161653912-chr1:161654635..161656635,2	K562	blood:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FCGR3B-2	chr1:161641768-161641939	ENSG00000234211.1
2	lnc-FCGR3B-6	chr1:161653495-161655042	NR_002595
3	lnc-FCGR3B-2	chr1:161642049-161642073	ENSG00000234211.1
4	lnc-FCRLA-1	chr1:161641182-161643019	NONHSAT007197
5	lnc-FCRLA-1	chr1:161640042-161640062	NONHSAT007197
6	lnc-FCGR3B-2	chr1:161644418-161644614	ENSG00000234211.1
7	lnc-FCRLA-1	chr1:161632989-161633143	NONHSAT007197
8	lnc-FCRLA-1	chr1:161643750-161643906	NONHSAT007197

No data

Variant related genes	Relation type
ENSG00000234211	TF binding region
FCGR2B	TF binding region
RPL31P11	TF binding region
ENSG00000199595	TF binding region
ENSG00000234211	CpG island
FCGR2B	CpG island
RPL31P11	CpG island
ENSG00000199595	CpG island
ENSG00000213075	chromatin interactions
ENSG00000132185	chromatin interactions
ENSG00000162746	chromatin interactions

Extended variants
information (count: 1795 )
Associated
traits (count: 110 )

Variant overlapped rSNPs/rCNVs (count:1795 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548427974	chr1:161612290-161612291	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs4573494	chr1:161612295-161612296	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs408849	chr1:161612340-161612341	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs4047663	chr1:161612375-161612376	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs4047664	chr1:161612376-161612377	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs4047665	chr1:161612378-161612379	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs140222026	chr1:161612395-161612396	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs549864648	chr1:161612407-161612408	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs61803040	chr1:161612410-161612411	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs374491677	chr1:161612429-161612430	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs2878011	chr1:161612476-161612477	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs555627161	chr1:161612490-161612491	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs372877511	chr1:161612520-161612521	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs572347733	chr1:161612533-161612534	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs529568363	chr1:161612550-161612551	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs112501186	chr1:161612558-161612559	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs2926468	chr1:161612578-161612579	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
18	rs1771587	chr1:161612610-161612611	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs1674770	chr1:161612615-161612616	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs370491719	chr1:161612622-161612623	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs576823616	chr1:161612649-161612650	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs188659020	chr1:161612650-161612651	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs60751059	chr1:161612666-161612667	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs576086852	chr1:161612681-161612682	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs369600419	chr1:161612682-161612683	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs542179054	chr1:161612695-161612696	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs1674797	chr1:161612752-161612753	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs61803049	chr1:161612839-161612840	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs364449	chr1:161612850-161612851	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs141914340	chr1:161612861-161612862	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs147268969	chr1:161612990-161612991	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs564613310	chr1:161613043-161613044	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs533232462	chr1:161613071-161613072	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs550168524	chr1:161613091-161613092	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs569752579	chr1:161613093-161613094	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs140743372	chr1:161613099-161613100	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs402012	chr1:161613128-161613129	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs565987892	chr1:161613176-161613177	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs535231103	chr1:161613181-161613182	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs558036424	chr1:161613203-161613204	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs576894305	chr1:161613223-161613224	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs539187230	chr1:161613250-161613251	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs386624	chr1:161613374-161613375	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs450272	chr1:161613391-161613392	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs4047666	chr1:161613392-161613393	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs4656323	chr1:161613419-161613420	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs576146488	chr1:161613423-161613424	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs424361	chr1:161613435-161613436	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs139389651	chr1:161613436-161613437	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs150060730	chr1:161613467-161613468	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:110)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Liposarcoma	21253554	CNVD
Non-small cell lung cancer	21385341	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	21183584	CNVD
Multiple myeloma	16461302	CNVD
Lung cancer	18438408	CNVD
Rett syndrome	21593744	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Systemic lupus erythematosus	21956041	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21829676	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	17899364	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Retinoblastoma	19183342	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Type 2 diabetes	19141583	CNVD
Chordoma	18071362	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Burkitt''s lymphoma	19759907	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21509527	CNVD
Bladder cancer	21909424	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	21611746	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Neuroblastoma	18923191	CNVD
Systemic lupus erythematosus	19220326	CNVD
Systemic lupus erythematosus	19287148	CNVD
Glomerulonephritis	19341492	CNVD
Systemic lupus erythematosus	18559452	CNVD
Systemic autoimmune disease	17597778	CNVD
Glomerulonephritis	17008540	CNVD
Glomerulonephritis	16482158	CNVD
Soft tissue tumor	16732325	CNVD
Cancer	17060936	CNVD
Lung cancer	16740712	CNVD
Breast cancer	21045282	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Follicular lymphoma	18703704	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20409316	CNVD
Mental retardation	17847001	CNVD
Idiopathic thrombocytopenic purpura	17827395	CNVD
Coronary artery disease	20973705	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:190 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:161607600-161612400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
2	chr1:161607600-161612400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
3	chr1:161607600-161617200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
4	chr1:161612000-161612600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
5	chr1:161612000-161613200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
6	chr1:161612000-161614200	Enhancers	Primary B cells from peripheral blood	blood
7	chr1:161612000-161615600	Enhancers	Primary monocytes fromperipheralblood	blood
8	chr1:161612200-161612400	Enhancers	Primary B cells from cord blood	blood
9	chr1:161612200-161612600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr1:161612200-161612600	Enhancers	GM12878-XiMat	blood
11	chr1:161612200-161612800	Enhancers	Primary T killer memory cells from peripheral blood	blood
12	chr1:161612200-161612800	Enhancers	K562	blood
13	chr1:161612400-161612600	Enhancers	Primary T cells fromperipheralblood	blood
14	chr1:161612400-161612600	Enhancers	Primary hematopoietic stem cells	blood
15	chr1:161612400-161612800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
16	chr1:161612400-161612800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr1:161612400-161613800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
18	chr1:161612600-161613000	Weak transcription	Primary B cells from cord blood	blood
19	chr1:161612600-161613000	Active TSS	Monocytes-CD14+_RO01746	blood
20	chr1:161612600-161617400	Weak transcription	GM12878-XiMat	blood
21	chr1:161612800-161616800	Weak transcription	K562	blood
22	chr1:161613000-161613400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
23	chr1:161613000-161613600	Active TSS	Primary B cells from cord blood	blood
24	chr1:161613200-161613600	Enhancers	Primary neutrophils fromperipheralblood	blood
25	chr1:161613400-161613800	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr1:161613600-161614400	Weak transcription	Primary B cells from cord blood	blood
27	chr1:161613600-161614600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
28	chr1:161613800-161614200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
29	chr1:161613800-161614600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
30	chr1:161614200-161614400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
31	chr1:161614200-161617200	Weak transcription	Primary B cells from peripheral blood	blood
32	chr1:161614400-161614600	Enhancers	Primary B cells from cord blood	blood
33	chr1:161614400-161617000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
34	chr1:161614600-161615000	Weak transcription	Primary B cells from cord blood	blood
35	chr1:161614600-161615800	Enhancers	Monocytes-CD14+_RO01746	blood
36	chr1:161614600-161617800	Enhancers	Primary neutrophils fromperipheralblood	blood
37	chr1:161615000-161615600	Enhancers	Primary B cells from cord blood	blood
38	chr1:161615600-161617000	Weak transcription	Primary monocytes fromperipheralblood	blood
39	chr1:161615800-161617200	Weak transcription	Monocytes-CD14+_RO01746	blood
40	chr1:161616800-161617400	Enhancers	K562	blood
41	chr1:161617000-161617800	Enhancers	Primary monocytes fromperipheralblood	blood
42	chr1:161617000-161618000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
43	chr1:161617200-161617600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr1:161617200-161617800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
45	chr1:161617200-161617800	Enhancers	Monocytes-CD14+_RO01746	blood
46	chr1:161617200-161618000	Enhancers	Primary B cells from peripheral blood	blood
47	chr1:161617400-161617800	Enhancers	Liver	Liver
48	chr1:161617400-161617800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr1:161617400-161617800	Enhancers	Rectal Mucosa Donor 31	rectum
50	chr1:161617400-161617800	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links